| [1] |
Spradley FT, Palei AC, Granger JP.Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms[J].Am J Physiol Regul Integr Comp Physiol,2015,309(11):1326-1343.
|
| [2] |
谈炯新, 刘怀昌, 肖磊,等. 初次妊娠高血压综合征患者再次妊娠发生子痫的高危因素[J]. 临床与病理杂志, 2020,40(1):62-66.
|
| [3] |
林秀英,付建华,芦小单,等. 机械刺激对子宫内膜中整合素avβ3、VEGF、LIF的影响[J]. 中国实验诊断学,2017,21(12):2136-2138.
|
| [4] |
赵招凤,朱礼鑫. 血清人γ干扰素诱导蛋白16、组织型转谷氨酰胺酶和内皮素水平与子痫前期的关系[J]. 中国妇幼保健,2018,33(12):2667-2669.
|
| [5] |
麻秀丽,鲁琦,张震宇. 妊娠期孕妇血清TTR水平变化及其用于诊断子痫前期的价值[J]. 现代妇产科进展,2016,25(7):523-526.
|
| [6] |
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2015)[J]. 中华妇产科杂志,2015,50(10):721-728.
|
| [7] |
乐怡平, 林建华. 子痫前期流行病学进展[J].中华产科急救电子杂志, 2013, 2(3):4-8.
|
| [8] |
Cohen JM, Beddaoui M, Kramer MS, et al.Maternal antioxidant levels in pregnancy and risk of preeclampsia and small for gestational age birth: A systematic review and meta-analysis[J]. PLoS One,2015,10(8):192-195.
|
| [9] |
Costantine MM, Cleary K, Hebert MF, et al.Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial[J]. Am J Obstet Gynecol, 2016,214(6):720-721.
|
| [10] |
March MI, Geahchan C, Wenger J, et al.Circulating angiogenic factors and the risk of adverse outcomes among Haitian women with preeclampsia[J]. PLoS One,2015,10(5):815-817.
|
| [11] |
方颖. 干扰素诱导蛋白16在子痫前期孕妇胎盘组织中表达水平及其与滋养细胞侵袭和胎盘缺氧的相关性分析[J]. 中国计划生育和妇产科,2018,10(11):63-66.
|
| [12] |
金艳. 子痫前期孕妇孕中期血清转甲状腺素蛋白的表达及其对妊娠结局的影响[J]. 中国妇幼保健,2017,32(14):3167-3169.
|
| [13] |
刘倩,林羿,张珺,等. 干扰素调节因子4在母胎界面的表达特点及作用[J]. 中华生物医学工程杂志,2016,22(5):392-397.
|
| [14] |
宋方,田茂波,肖燕,等. 干扰素诱导蛋白p204过表达抑制大鼠主动脉血管外膜成纤维细胞凋亡、增殖与迁移[J]. 中国循环杂志,2015,30(11):1110-1114.
|
